Yüklüyor......
Preclinical development of CD126 CAR-T cells with broad antitumor activity
Chimeric antigen receptor T (CAR-T) cell therapy is a transformative approach to cancer eradication. CAR-T is expensive partly due to the restricted use of each CAR construct for specific tumors. Thus, a CAR construct with broad antitumor activity can be advantageous. We identified that CD126 is exp...
Kaydedildi:
| Yayımlandı: | Blood Cancer J |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group UK
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7791061/ https://ncbi.nlm.nih.gov/pubmed/33414408 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-020-00405-z |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|